Apple and Palantir shares slide in premarket trading following post-bell earnings
Apple (AAPL) and Palantir (PLTR) shares declined in premarket trading Tuesday after reporting earnings. Apple's revenue exceeded expectations, but iPad sales and margin forecasts missed estimates. Palantir beat estimates, with U.S. commercial revenue surpassing government revenue for the first time.
How this was made

The 30-second read
Why it matters
The earnings miss on margins for Apple and the broader market sell‑off despite Palantir's beat suggest short‑term downside risk for large‑cap tech names.
Market read
Earnings-driven price moves in two high‑profile tech stocks provide immediate trading opportunities.
What to watch
Potential upside from Palantir's shift to commercial revenue and Apple's strong overall revenue growth.
Background
Both Apple and Palantir released earnings after the bell, prompting immediate pre‑market price reactions.
Ticker impact
Apple reported Q4 revenue beat but missed iPad sales estimates and gave a weak margin forecast, causing the stock to drop 4.4% in pre‑market trading.
downward pressure as the market prices in weaker margins
Margin guidance is a key driver for valuation; a miss typically triggers sell‑offs in the near term.
Palantir posted a Q3 beat and saw U.S. commercial revenue overtake government revenue for the first time, yet the stock fell 5.9% in pre‑market trading.
downward pressure as investors remain cautious after the earnings surprise
Even with a beat, the broader market reaction suggests profit‑taking and concerns over future growth.
Market effects
Tech sector may see broader pressure as margin guidance concerns spread to peers.
U.S. markets likely open lower on the earnings disappointment.
Limited to U.S. equities; no immediate global macro impact.
Counterpoint
The price drops may present a buying opportunity if the earnings beat is sustainable.
Key entities
- CompanyApple Inc.
Technology hardware and services giant.
- CompanyPalantir Technologies Inc.
Data analytics and software provider.
